Related Experiment Videos
Therapeutics and mild cognitive impairment: current status and future directions
1Department of Neuroscience, University of California, San Diego School of Medicine, La Jolla, California 92093, USA. lthal@ucsd.edu
Alzheimer Disease and Associated Disorders
|June 19, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.
Human brain mapping·2010
Alzheimer's Association Research Roundtable Meeting on Mild Cognitive Impairment: what have we learned?
Alzheimer's & dementia : the journal of the Alzheimer's Association·2009
Utility of the telephone interview for cognitive status for enrollment in clinical trials.
Alzheimer's & dementia : the journal of the Alzheimer's Association·2009
Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders.
Current Alzheimer research·2009
Dementia With Extensive Giant Perivascular Spaces as a Mimicker of Alzheimer Disease: A Case Report.
Alzheimer disease and associated disorders·2026
Content Validity of the Quality of Interactions Inventory (QUALII) in Assisted Living.
Alzheimer disease and associated disorders·2026
Post Hoc Subgroup Analysis by Disease Severity in a Non-Inferiority Trial of Donepezil 27.5 mg Transdermal Formulation in Japanese Patients With Mild-to-Moderate Alzheimer Disease.
Alzheimer disease and associated disorders·2026
CHMP2B p.Ala30Ser Variant in Biomarker-Confirmed Early-Onset Alzheimer Disease: A Potential Endolysosomal Disease Modifier.
Alzheimer disease and associated disorders·2026
Early Gut Microbiome Alterations in Mild Cognitive Impairment Reflect Changes in Alzheimer Disease.
Alzheimer disease and associated disorders·2026
Improvements in Cogstate Test Performance Depend on Number and Frequency of Prior Tests: Evidence from a Randomized Follow-Up Design.
Alzheimer disease and associated disorders·2026
Research Progress in Pharmacological Targeted Therapy for Myasthenia Gravis.
Journal of inflammation research·2026
Adverse effects of vanzacaftor-tezacaftor-deutivacaftor in a cystic fibrosis population: A case series.
Respiratory medicine case reports·2026